Twist Bioscience (TWST) Cash Flow: Operating & Free Cash Flow

Twist Bioscience Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Twist Bioscience Corporation (TWST) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017
Operating Activities
Net Income	-77.67	-208.73	-204.62	-217.86	-152.10	-139.93	-107.67	-71.24	-59.31
Depreciation & Amortization	24.85	31.43	29.31	16.51	9.75	6.68	6.11	5.73	5.02
Deferred Income Tax	0.00	0.00	-0.41	0.00	0.00	-0.21	-1.06	0.04	0.77
Stock Based Compensation	64.46	50.93	30.28	79.66	37.00	17.10	11.17	2.96	1.89
Change in Working Capital	-12.61	15.41	-1.01	-5.36	-9.38	-25.18	3.00	-4.22	-0.13
Change in Accounts Receivable	-22.38	8.44	-4.32	-9.62	-2.20	-14.27	-6.69	-3.07	-1.62
Change in Inventory	-4.23	7.99	7.24	-7.54	-19.49	-4.96	-1.30	-4.20	-0.60
Change in Accounts Payable	9.33	-11.81	-2.51	7.38	8.54	-5.51	3.28	3.76	0.56
Change in Other Working Capital	4.67	-1.50	-2.90	4.42	3.77	-0.44	7.71	-0.70	1.53
Other Operating Activities	-46.66	46.86	3.57	2.66	2.49	-0.71	0.52	0.56	0.46
Net Cash from Operating Activities	-47.63	-64.09	-142.47	-124.39	-112.24	-142.26	-87.94	-66.16	-51.30
Investing Activities
Capital Expenditures	-28.00	-5.08	-27.78	-101.86	-27.06	-9.87	-14.76	-3.69	-6.59
Acquisitions	2.50	0.00	5.86	-8.16	-0.48	104.78	0.02	0.02	0.27
Purchases of Investments	-49.39	-51.91	-76.35	-217.64	-58.80	-202.88	-177.57	-3.52	-40.59
Sales/Maturities of Investments	50.14	53.91	154.74	100.48	242.49	98.10	87.50	34.50	36.93
Other Investing Activities	0.00	0.00	-5.86	-5.76	0.00	-104.78	-90.05	-0.43	0.12
Net Cash from Investing Activities	-24.76	-3.07	50.61	-232.93	156.16	-114.65	-104.81	26.87	-9.87
Financing Activities
Debt Repayment	0.00	0.00	0.00	-1.56	-3.33	-3.33	-2.50	0.00	-2.00
Common Stock Issued	13.56	10.87	5.32	269.82	323.86	295.56	156.21	0.33	0.21
Common Stock Repurchased	-0.02	-3.98	-4.41	-7.75	-10.85	-2.42	0.00	0.00	0.00
Other Financing Activities	15.00	10.87	5.32	10.02	19.50	13.92	4.87	88.82	65.80
Net Cash from Financing Activities	28.54	6.89	0.91	270.53	329.18	303.73	158.58	88.82	63.80
Summary
Effect of Forex Changes on Cash	0.58	0.13	-0.03	-0.32	0.02	0.02	0.03	0.00	0.00
Net Change in Cash	-43.27	-60.15	-90.98	-87.10	373.11	46.85	-34.14	49.53	2.63
Cash at Beginning of Period	226.32	289.28	380.26	467.36	94.25	47.40	81.54	31.23	28.60
Cash at End of Period	183.05	229.13	289.28	380.26	467.36	94.25	47.40	80.76	31.23
Free Cash Flow	-75.63	-69.17	-170.25	-226.24	-139.31	-152.12	-102.69	-69.85	-57.90
Supplemental Disclosures
Interest Paid	-	-	-	0.01	0.17	-	-	-	-
Income Taxes Paid	0.68	0.34	0.42	0.25	0.10	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Twist Bioscience Cash Flow

What is Twist Bioscience's free cash flow?

Twist Bioscience had negative free cash flow of $75.63M in fiscal 2025 (fiscal year ended Sep 30, 2025), operating cash flow of −$47.63M minus $28.00M of capital expenditures.

How much does Twist Bioscience spend on capital expenditures?

Twist Bioscience spent $28.00M on capital expenditures in fiscal 2025, compared with $5.08M a year earlier.

Does Twist Bioscience pay dividends or buy back shares?

Yes. In fiscal 2025 Twist Bioscience returned $16.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition